GOLD Program for Childhood Cancer Family Support
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to support caregivers of children recently diagnosed with cancer through a new virtual program called the GOLD Program. The program includes a 2-hour session focused on understanding cancer treatments, coping strategies, and stress management. It compares this new method with usual support practices to determine which is more effective. The trial is suitable for English-speaking parents of children diagnosed with cancer in the past year. As an unphased trial, this study provides a unique opportunity to access innovative support methods early.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on support for caregivers, so it's unlikely that medication changes are required.
What prior data suggests that the GOLD Program is safe for caregivers of youth with cancer?
Research shows that the GOLD Program supports and educates caregivers of children with cancer. This program helps families manage stress and understand the side effects of cancer treatments through online sessions.
Because the program provides information and coping strategies, it is expected to be well-received. No negative effects or side effects are known from participating in this type of program. The sessions include discussions and activities designed to reduce anxiety and build strength, which are generally safe for participants.12345Why are researchers excited about this trial?
The GOLD Program is unique because it focuses on providing psychosocial support to families dealing with childhood cancer, which is an area often overlooked by standard medical treatments. Most existing treatments for childhood cancer primarily address the physical aspects of the disease, such as chemotherapy and radiation. However, the GOLD Program offers a 2-hour intervention session that includes psychoeducation and coping strategies, as well as stress and self-care techniques. Researchers are excited about this approach because it aims to support not just the patient, but the entire family, potentially improving emotional resilience and quality of life during a challenging time.
What evidence suggests that the GOLD Program is effective for supporting families of youth with cancer?
Studies have shown that the GOLD Program, a treatment option in this trial, can reduce anxiety and stress in caregivers of children with cancer. This program includes a 2-hour session that teaches coping strategies and provides information about cancer treatment side effects. Early results suggest that caregivers who participate feel stronger and better prepared to manage their child's illness. The program aims to enhance the well-being of the entire family by addressing stress and emotional responses. Research indicates that such support programs effectively boost mental health and resilience in families facing childhood cancer.12367
Who Is on the Research Team?
Victoria E. Cosgrove, PhD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for primary caregivers of children under 18 recently diagnosed with blood or brain/CNS cancer. Caregivers must be proficient in English and able to consent to research. Children/siblings over age 8 can also participate. Those with active suicidal thoughts or not caring for a child diagnosed within the last six months are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a 2-hour interventional session consisting of psychoeducation and coping, and stress, triggers, and self-care modules
Follow-up
Participants are monitored for feasibility, acceptability, and psychological distress symptoms after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- GOLD Program
- Treatment as usual (TAU)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor